Retrospect 74/8/2023 ![]() One sole case of post-transplant EBV lymphoproliferative disorder was diagnosed 24 months after conversion. N=23 (20%) opportunistic infections occurred after 12 (2-19) months. Incidence of acute rejection was 12% with 15 episodes. 5-years patient and kidney allograft survivals were 76% and 78% respectively (Figure 1). Late conversion median delay was 16 (9-67) months. Among those, N=39 (34%) switch were performed within the first 3 months after transplant. Results: A total of 114 kidney transplant recipients were included and followed 19 (7-46) months. ![]() We analyzed kidney allograft function (estimated glomerular filtration rate (eGFR)) evolution, allograft and patient survivals, acute rejection and opportunistic infections incidences, anti-HLA donor specific antibody (DSA) profile and histology evolution after the switch. Methods: In this single-center retrospective study, we collected all patients with switch from CNI-based immunosuppressive therapy to Belatacept from 01/2012 to 12/2018.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |